Skip Navigation

Schizophrenia Bulletin 1998 24(3):443-455;
© 1998 by Oxford University Press and the Maryland Psychiatric Research Center (MPRC)
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Fowler, I. L.
Right arrow Articles by Lewin, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fowler, I. L.
Right arrow Articles by Lewin, T. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press

Patterns of Current and Lifetime Substance Use in Schizophrenia

Ian L. Fowler, M.B.B.S., F.R.A.N.Z.C.P., Vaughan J. Carr, M.D., F.R.C.P.C., F.R.A.N.Z.C.P., Natalia T. Carter, B.Sc. Hons and Terry J. Lewin, B.Com(Psych)
psychiatrist in private practice, Discipline of Psychiatry, Faculty of Medicine and Health Sciences, University of Newcastle New South Wales, Australia
Professor of Psychiatry and Director of Hunter Mental Health Services, Discipline of Psychiatry, Faculty of Medicine and Health Sciences, University of Newcastle New South Wales, Australia
Research Assistant and Medical Student, Discipline of Psychiatry, Faculty of Medicine and Health Sciences, University of Newcastle New South Wales, Australia
Professional Officer, Discipline of Psychiatry, Faculty of Medicine and Health Sciences, University of Newcastle New South Wales, Australia

Reprint requests should be Sent to Prof. V.J. Carr, Discipline Psychiatry, Faculty of Medicine and Health Sciences, University of New Castle, Callaghan, N.S.W. 2308, Australia

A structured interview and standardized rating scales were used to assess a sample of 194 outpatients with schizophrenia in a regional Australian mental health service for substance use, abuse, and dependence. Case manager assessments and urine drug screens were also used to determine substance use. Additional measurements included demographic information, history of criminal charges, symptom self-reports, personal hopefulness, and social support. The sample was predominantly male and showed relative instability in accommodations, and almost half had a history of criminal offenses, most frequently drug or alcohol related. The 6-month and lifetime prevalence of substance abuse or dependence was 26.8 and 59.8 percent, respectively, with alcohol, cannabis, and amphetamines being the most commonly abused substances. Current users of alcohol comprised 77.3 percent and current users of other nonprescribed substances (excluding tobacco and caffeine) comprised 29.9 percent of the sample. Rates of tobacco and caffeine consumption were high. There was a moderate degree of concordance between case manager determinations of a substance-use problem and research diagnoses. Subjects with current or lifetime diagnoses of substance abuse/dependence were predominantly young, single males with higher rates of criminal charges; however, there was no evidence of increased rates of suicide attempts, hospital admissions, or daily doses of antipsychotic drugs in these groups compared with subjects with no past or current diagnosis of substance abuse or dependence. Subjects with a current diagnosis of substance use were younger at first treatment and currently more symptomatic than those with no past or current substance use diagnosis. The picture emerging from this study replicates the high rate of substance abuse in persons with schizophrenia reported in North American studies but differs from the latter in finding a slightly different pattern of substances abused (i.e., absence of cocaine), reflecting relative differences in the availability of certain drugs.

Keywords: Substance abuse / alcohol / cannabis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Schizophr BullHome page
N. D. Volkow
Substance Use Disorders in Schizophrenia--Clinical Implications of Comorbidity
Schizophr Bull, May 1, 2009; 35(3): 469 - 472.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
J. Koskinen, J. Lohonen, H. Koponen, M. Isohanni, and J. Miettunen
Rate of Cannabis Use Disorders in Clinical Samples of Patients With Schizophrenia: A Meta-analysis
Schizophr Bull, April 22, 2009; (2009) sbp031v1.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
P. M. Wye, J. A. Bowman, J. H. Wiggers, A. Baker, J. Knight, V. J. Carr, M. Terry, and R. Clancy
Smoking Restrictions and Treatment for Smoking: Policies and Procedures in Psychiatric Inpatient Units in Australia
Psychiatr Serv, January 1, 2009; 60(1): 100 - 107.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
K. T. Mueser, A. G. Crocker, L. B. Frisman, R. E. Drake, N. H. Covell, and S. M. Essock
Conduct Disorder and Antisocial Personality Disorder in Persons With Severe Psychiatric and Substance Use Disorders
Schizophr Bull, October 1, 2006; 32(4): 626 - 636.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
B. GREEN, R. YOUNG, and D. KAVANAGH
Cannabis use and misuse prevalence among people with psychosis
The British Journal of Psychiatry, October 1, 2005; 187(4): 306 - 313.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
D. A. Bigelow, B. H. McFarland, L. E. McCamant, D. D. Deck, and R. M. Gabriel
Effect of Managed Care on Access to Mental Health Services Among Medicaid Enrollees Receiving Substance Treatment
Psychiatr Serv, July 1, 2004; 55(7): 775 - 779.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
V. J. Carr, P. J. Johnston, T. J. Lewin, S. Rajkumar, G. L. Carter, and C. Issakidis
Patterns of Service Use Among Persons With Schizophrenia and Other Psychotic Disorders
Psychiatr Serv, February 1, 2003; 54(2): 226 - 235.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.